carmustine has been researched along with Chromosome-Defective Micronuclei in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morales-RamÃrez, P | 1 |
Vallarino-Kelly, T | 1 |
Cruz-Vallejo, VL | 1 |
Ferguson, LR | 1 |
Hill, CL | 1 |
Morecombe, P | 1 |
2 other studies available for carmustine and Chromosome-Defective Micronuclei
Article | Year |
---|---|
Effect of O6-chloroethylguanine DNA lesions on the kinetics and mechanism of micronucleus induction in vivo.
Topics: Animals; Antineoplastic Agents, Alkylating; Carmustine; DNA Damage; Dose-Response Relationship, Drug | 2010 |
Induction of resistance to 6-thioguanine and cytarabine by a range of anticancer drugs in Chinese hamster AA8 cells.
Topics: Amsacrine; Animals; Antineoplastic Agents; Bleomycin; Carmustine; CHO Cells; Clone Cells; Cricetinae | 1992 |